null - FindTrial

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10003416 Term: Arthrosis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders

José María Lamo-Espinosa, Álvaro Suárez, Jorge M. Núñez‐Córdoba, Juan F. Blanco, Mikel Sánchez et al. (23 authors)

Diagnostics2025-01-28

10.3390/diagnostics15030309

Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis.

Lamo-Espinosa JM, Blanco JF, Sánchez M, Moreno V, Granero-Moltó F, Sánchez-Guijo F, Crespo-Cullel Í, Mora G, San Vicente DD, Pompei-Fernández O, Aquerreta JD, Núñez-Córdoba JM, Vitoria Sola M, Valentí-Azcárate A, Andreu EJ, Del Consuelo Del Cañizo M, Valentí-Nin JR, Prósper F.

2020-09-1883 citations

10.1186/s12967-020-02530-6

Interventions

Product Name: células madre progenitoras mesenquimales autólogas cultivadas ex-vivo Product Code: células madre progenitoras mesenquimales autólogas Pharmaceutical Form: Suspension for injection INN o

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 10 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 28

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Spain

Contacts

Public ContactUnidad Central Investigación Clínic

Clinica Universidad de Navarra

ucicec@unav.es948 255 4001144

Outcome results

None listed